Journals / art / 2018 / Cilt: 33 - Sayı: 2

Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma

Journal
art
Pages
230–235
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results demonstrated that MRI is useful for the evaluation of treatment effects for localized scleroderma in children.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Children with localized scleroderma may have more serious sequelae than adults with the disease.
📊
Key Findings & Data:In this case report, we analyzed four girls with localized scleroderma (generalized morphea) to evaluate the clinical usefulness of magnetic resonance imaging (MRI) in facilitating disease control and investigating patient responsiveness to various treatments.
💡
Conclusion & Impact:Our results demonstrated that MRI is useful for the evaluation of treatment effects for localized scleroderma in children.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Children with localized scleroderma may have more serious sequelae than adults with the disease. In this case report, we analyzed four girls with localized scleroderma (generalized morphea) to evaluate the clinical usefulness of magnetic resonance imaging (MRI) in facilitating disease control and investigating patient responsiveness to various treatments. Two of the children had flexion contracture, and two displayed a clear high-intensity area in the bone marrow under the sclerotic skin on MRI. Two girls had different bilateral circumferences of the legs or forearms. These abnormalities were detected without any obvious changes in blood chemistry. Our results demonstrated that MRI is useful for the evaluation of treatment effects for localized scleroderma in children.

🔖

Cite This Article

AGATA, K., KAWASHIMA, H., KUMADA, A., KASHIWAGI, Y., HARA, H. (2018). Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma. art, Cilt: 33 - Sayı: 2, 230–235. https://ajindex.com/articles/156452

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, et al. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). J Am Acad Dermatol 2012;67:1151-6. Torok KS. Pediatric scleroderma: systemic or localized forms. Pediatr Clin North Am 2012;59:381-405.
  2. Kashiwagi Y, Kawashima H, Agata K, Akaba M, Hirose A, Go S, et al. Thermography for evaluation of localized scleroderma treated with methotrexate and corticosteroid. Indian J Pediatr 2013;80:980-1.
  3. Schanz S, Henes J, Ulmer A, Kötter I, Fierlbeck G, Claussen CD, et al. Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach. AJR Am J Roentgenol 2013;200:376-82.
  4. Schanz S, Henes J, Ulmer A, Kötter I, Fierlbeck G, Claussen CD, et al. Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms. Eur Radiol 2013;23:212-21.
  5. Muroi E, Ogawa F, Yamaoka T, Sueyoshi F, Sato S. Case of localized scleroderma associated with osteomyelitis. J Dermatol 2010;37:81-4.
  6. Liu P, Uziel Y, Chuang S, Silverman E, Krafchik B, Laxer R. Localized scleroderma: imaging features. Pediatr Radiol 1994;24:207-9.
  7. Horger M, Fierlbeck G, Kuemmerle-Deschner J, Tzaribachev N, Wehrmann M, Claussen CD, et al. MRI findings in deep and generalized morphea (localized scleroderma). AJR Am J Roentgenol 2008;190:32-9.
  8. Schanz S, Fierlbeck G, Ulmer A, Schmalzing M, Kümmerle-Deschner J, Claussen CD, et al. Localized scleroderma: MR findings and clinical features. Radiology 2011;260:817-24.
  9. Uziel Y, Krafchik BR, Feldman B, Silverman ED, Rubin LA, Laxer RM. Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma. Arthritis Rheum 1994;37:898-901.
  10. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000;136:91-5.
  11. Kawashima H, Watanabe C, Kashiwagi Y, Sato S, Ioi H, Sasamoto M, et al. Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases. Pediatr Int 2006;48:342-5.
  12. Diaz-Perez JL, Connolly SM, Winkelmann RK. Disabling pansclerotic morphea of children. Arch Dermatol 1980;116:169-73.
  13. Christianson HB, Dorsey CS, Kierland RR, O’leary PA. Localized scleroderma; a clinical study of two hundred thirty-five cases. AMA Arch Derm 1956;74:629-39.
  14. Uziel Y, Krafchik BR, Silverman ED, Thorner PS, Lax